OMI PE Ratio & Valuation,Is OMI Overvalued

OMI Relative Valuation

OMI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OMI is overvalued; if below, it's undervalued.

Historical Valuation

Accendra Health Inc (OMI) is now in the Undervalued zone, suggesting that its current forward PE ratio of 3.40 is considered Undervalued compared with the five-year average of 10.59. The fair price of Accendra Health Inc (OMI) is between 6.81 to 11.97 according to relative valuation methord. Compared to the current price of 2.86 USD , Accendra Health Inc is Undervalued By 57.98%.

Relative Value

Fair Zone

6.81-11.97

Current Price：2.86

57.98%

Undervalued

3.40

6.71

EV/EBITDA

Accendra Health Inc. (OMI) has a current EV/EBITDA of 6.71. The 5-year average EV/EBITDA is 7.29. The thresholds are as follows: Strongly Undervalued below 4.04, Undervalued between 4.04 and 5.67, Fairly Valued between 8.92 and 5.67, Overvalued between 8.92 and 10.55, and Strongly Overvalued above 10.55. The current Forward EV/EBITDA of 6.71 falls within the Historic Trend Line -Fairly Valued range.

11.37

EV/EBIT

Accendra Health Inc. (OMI) has a current EV/EBIT of 11.37. The 5-year average EV/EBIT is 10.95. The thresholds are as follows: Strongly Undervalued below 7.58, Undervalued between 7.58 and 9.27, Fairly Valued between 12.63 and 9.27, Overvalued between 12.63 and 14.32, and Strongly Overvalued above 14.32. The current Forward EV/EBIT of 11.37 falls within the Historic Trend Line -Fairly Valued range.

0.08

Accendra Health Inc. (OMI) has a current PS of 0.08. The 5-year average PS is 0.18. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.09, Fairly Valued between 0.27 and 0.09, Overvalued between 0.27 and 0.35, and Strongly Overvalued above 0.35. The current Forward PS of 0.08 falls within the Undervalued range.

0.73

P/OCF

Accendra Health Inc. (OMI) has a current P/OCF of 0.73. The 5-year average P/OCF is 4.54. The thresholds are as follows: Strongly Undervalued below -0.93, Undervalued between -0.93 and 1.81, Fairly Valued between 7.28 and 1.81, Overvalued between 7.28 and 10.02, and Strongly Overvalued above 10.02. The current Forward P/OCF of 0.73 falls within the Undervalued range.

1.46

P/FCF

Accendra Health Inc. (OMI) has a current P/FCF of 1.46. The 5-year average P/FCF is 6.18. The thresholds are as follows: Strongly Undervalued below 0.33, Undervalued between 0.33 and 3.25, Fairly Valued between 9.10 and 3.25, Overvalued between 9.10 and 12.03, and Strongly Overvalued above 12.03. The current Forward P/FCF of 1.46 falls within the Undervalued range.

Accendra Health Inc (OMI) has a current Price-to-Book (P/B) ratio of -0.50. Compared to its 3-year average P/B ratio of 1.01 , the current P/B ratio is approximately -149.96% higher. Relative to its 5-year average P/B ratio of 1.81, the current P/B ratio is about -127.78% higher. Accendra Health Inc (OMI) has a Forward Free Cash Flow (FCF) yield of approximately -156.92%. Compared to its 3-year average FCF yield of -0.29%, the current FCF yield is approximately 53471.74% lower. Relative to its 5-year average FCF yield of 2.61% , the current FCF yield is about -6106.41% lower.

-0.50

P/B

Median3y

1.01

Median5y

1.81

-156.92

FCF Yield

Median3y

-0.29

Median5y

2.61

Competitors Valuation Multiple

The average P/S ratio for OMI's competitors is 150.41, providing a benchmark for relative valuation. Accendra Health Inc Corp (OMI) exhibits a P/S ratio of 0.08, which is -99.95% above the industry average. Given its robust revenue growth of 1.52%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of OMI decreased by 80.34% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.09 to -0.49.

The secondary factor is the Revenue Growth, contributed 1.52%to the performance.

Overall, the performance of OMI in the past 1 year is driven by P/E Change. Which is more unsustainable.

1.52%

686.85M → 697.26M

Revenue Growth

-544.44%

0.18 → -0.80

Margin Expansion

462.58%

-0.09 → -0.49

P/E Change

-80.34%

14.24 → 2.80

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Accendra Health Inc (OMI) currently overvalued or undervalued?

What is Accendra Health Inc (OMI) fair value?

OMI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Accendra Health Inc (OMI) is between 6.81 to 11.97 according to relative valuation methord.

How does OMI's valuation metrics compare to the industry average?

What is the current P/B ratio for Accendra Health Inc (OMI) as of Jan 09 2026?

As of Jan 09 2026, Accendra Health Inc (OMI) has a P/B ratio of -0.50. This indicates that the market values OMI at -0.50 times its book value.

What is the current FCF Yield for Accendra Health Inc (OMI) as of Jan 09 2026?

As of Jan 09 2026, Accendra Health Inc (OMI) has a FCF Yield of -156.92%. This means that for every dollar of Accendra Health Inc’s market capitalization, the company generates -156.92 cents in free cash flow.

What is the current Forward P/E ratio for Accendra Health Inc (OMI) as of Jan 09 2026?

As of Jan 09 2026, Accendra Health Inc (OMI) has a Forward P/E ratio of 3.40. This means the market is willing to pay $3.40 for every dollar of Accendra Health Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Accendra Health Inc (OMI) as of Jan 09 2026?

As of Jan 09 2026, Accendra Health Inc (OMI) has a Forward P/S ratio of 0.08. This means the market is valuing OMI at $0.08 for every dollar of expected revenue over the next 12 months.

OMI Valuation